Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1964 1
1968 1
1969 1
1975 2
1976 4
1977 6
1978 6
1979 2
1980 7
1981 7
1982 6
1983 11
1984 1
1985 8
1986 14
1987 18
1988 20
1989 10
1990 11
1991 20
1992 5
1993 6
1994 10
1995 7
1996 10
1997 5
1998 6
1999 19
2000 18
2001 15
2002 21
2003 32
2004 38
2005 39
2006 52
2007 63
2008 47
2009 75
2010 67
2011 98
2012 94
2013 158
2014 141
2015 124
2016 156
2017 175
2018 143
2019 151
2020 168
2021 202
2022 180
2023 199
2024 126

Text availability

Article attribute

Article type

Publication date

Search Results

2,470 results

Results by year

Filters applied: . Clear all
Page 1
Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trial.
Agarwal N, Azad AA, Carles J, Fay AP, Matsubara N, Heinrich D, Szczylik C, De Giorgi U, Young Joung J, Fong PCC, Voog E, Jones RJ, Shore ND, Dunshee C, Zschäbitz S, Oldenburg J, Lin X, Healy CG, Di Santo N, Zohren F, Fizazi K. Agarwal N, et al. Lancet. 2023 Jul 22;402(10398):291-303. doi: 10.1016/S0140-6736(23)01055-3. Epub 2023 Jun 4. Lancet. 2023. PMID: 37285865 Clinical Trial.
Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
Motzer RJ, Jonasch E, Agarwal N, Alva A, Baine M, Beckermann K, Carlo MI, Choueiri TK, Costello BA, Derweesh IH, Desai A, Ged Y, George S, Gore JL, Haas N, Hancock SL, Kapur P, Kyriakopoulos C, Lam ET, Lara PN, Lau C, Lewis B, Madoff DC, Manley B, Michaelson MD, Mortazavi A, Nandagopal L, Plimack ER, Ponsky L, Ramalingam S, Shuch B, Smith ZL, Sosman J, Dwyer MA, Gurski LA, Motter A. Motzer RJ, et al. Among authors: agarwal n. J Natl Compr Canc Netw. 2022 Jan;20(1):71-90. doi: 10.6004/jnccn.2022.0001. J Natl Compr Canc Netw. 2022. PMID: 34991070 Free PMC article.
NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022.
Flaig TW, Spiess PE, Abern M, Agarwal N, Bangs R, Boorjian SA, Buyyounouski MK, Chan K, Chang S, Friedlander T, Greenberg RE, Guru KA, Herr HW, Hoffman-Censits J, Kishan A, Kundu S, Lele SM, Mamtani R, Margulis V, Mian OY, Michalski J, Montgomery JS, Nandagopal L, Pagliaro LC, Parikh M, Patterson A, Plimack ER, Pohar KS, Preston MA, Richards K, Sexton WJ, Siefker-Radtke AO, Tollefson M, Tward J, Wright JL, Dwyer MA, Cassara CJ, Gurski LA. Flaig TW, et al. Among authors: agarwal n. J Natl Compr Canc Netw. 2022 Aug;20(8):866-878. doi: 10.6004/jnccn.2022.0041. J Natl Compr Canc Netw. 2022. PMID: 35948037
Sickle Cell Anemia.
Mangla A, Ehsan M, Agarwal N, Maruvada S. Mangla A, et al. Among authors: agarwal n. 2023 Sep 4. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2023 Sep 4. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 29489205 Free Books & Documents.
Editorial Comment.
Sahu KK, Agarwal N. Sahu KK, et al. Among authors: agarwal n. J Urol. 2023 Jan;209(1):130. doi: 10.1097/JU.0000000000002969.01. Epub 2023 Jan 1. J Urol. 2023. PMID: 36484444 No abstract available.
Editorial Comment.
Narang A, Agarwal N. Narang A, et al. Among authors: agarwal n. Urol Pract. 2024 Jan;11(1):161. doi: 10.1097/UPJ.0000000000000487.01. Epub 2024 Jan 1. Urol Pract. 2024. PMID: 38117973 No abstract available.
Advances in the treatment of metastatic prostate cancer.
Gebrael G, Fortuna GG, Sayegh N, Swami U, Agarwal N. Gebrael G, et al. Among authors: agarwal n. Trends Cancer. 2023 Oct;9(10):840-854. doi: 10.1016/j.trecan.2023.06.009. Epub 2023 Jul 11. Trends Cancer. 2023. PMID: 37442702 Review.
Deep, rapid, and durable prostate-specific antigen decline with apalutamide plus androgen deprivation therapy is associated with longer survival and improved clinical outcomes in TITAN patients with metastatic castration-sensitive prostate cancer.
Chowdhury S, Bjartell A, Agarwal N, Chung BH, Given RW, Pereira de Santana Gomes AJ, Merseburger AS, Özgüroğlu M, Juárez Soto Á, Uemura H, Ye D, Brookman-May SD, Londhe A, Bhaumik A, Mundle SD, Larsen JS, McCarthy SA, Chi KN. Chowdhury S, et al. Among authors: agarwal n. Ann Oncol. 2023 May;34(5):477-485. doi: 10.1016/j.annonc.2023.02.009. Epub 2023 Feb 27. Ann Oncol. 2023. PMID: 36858151 Free article. Clinical Trial.
Editorial Comment.
Swami U, Agarwal N. Swami U, et al. Among authors: agarwal n. J Urol. 2021 Dec;206(6):1429. doi: 10.1097/JU.0000000000002121.01. Epub 2021 Aug 30. J Urol. 2021. PMID: 34455827 No abstract available.
2,470 results